The official 2024 immunization schedules with new vaccine recommendations for children and adolescents and for adults are now available from CDC. The updated schedules are being published ahead of time.
CDC released the 2024 immunization schedules with several changes. Notably, CDC added vaccines for meningococcal disease and mpox to the immunization schedules following recommendations from ACIP. For meningococcal disease, CDC has included information about the use of the newly licensed MenACWY-TT/MenB-FHbp (Penbraya) vaccine. They also developed a resource to assist health care providers with shared clinical decision-making recommendations for this particular vaccination. Information was added for the mpox vaccine (Jynneos) for those aged 18 years who are at risk.
CDC deleted the following vaccines from the 2024 schedules because they are no longer distributed or recommended: bivalent mRNA COVID-19 vaccines, 13-valent pneumococcal conjugate vaccine (PCV13), diphtheria and tetanus toxoid vaccine, and Menactra meningococcal conjugate vaccine.
The schedules summarize final recommendations that are official by CDC. Comprehensive details will be published in CDC’s Morbidity and Mortality Report in early 2024.